NYSE:ALB - Albemarle Stock Price, Price Target & More

$97.75 -0.84 (-0.85 %)

(As of 04/23/2018 01:36 AM ET)

Previous Close$98.59

Today's Range$97.11 - $98.32

52-Week Range$86.75 - $144.99

Volume912,300 shs

Average Volume2.30 million shs

Market Capitalization$10.81 billion

P/E Ratio21.30

Dividend Yield1.36%

Beta1.66

About Albemarle (NYSE:ALB)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium and Advanced Materials segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and automobiles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical markets; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. In addition, this segment offers performance catalyst solutions comprising organometallics, polymer catalysts, and curatives for polyolefin polymers, packaging, non-packaging, films, injection molding, alpha-olefins, polyurethanes, epoxies, and engineered resins markets. Its Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Refining Solutions segment offers clean fuels technologies, which is primarily composed of hydroprocessing catalysts; and fluidized catalytic cracking catalysts and additives for refining industry. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina.

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Plastics materials & resins

Sub-IndustrySpecialty Chemicals

SectorBasic Materials

SymbolNYSE:ALB

CUSIP01265310

Webwww.albemarle.com

Phone980-299-5700

Debt

Debt-to-Equity Ratio0.37%

Current Ratio2.06%

Quick Ratio1.57%

Price-To-Earnings

Trailing P/E Ratio21.30

Forward P/E Ratio18.98

P/E Growth1.17

Sales & Book Value

Annual Sales$3.07 billion

Price / Sales3.52

Cash Flow$6.4479 per share

Price / Cash15.16

Book Value$34.55 per share

Price / Book2.83

Profitability

EPS (Most Recent Fiscal Year)$4.59

Net Income$54.85 million

Net Margins1.79%

Return on Equity13.27%

Return on Assets6.89%

Miscellaneous

Employees5,400

Outstanding Shares110,640,000

How to Become a New Pot Stock Millionaire

Albemarle (NYSE:ALB) Frequently Asked Questions

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle announced a quarterly dividend on Friday, February 23rd. Shareholders of record on Thursday, March 15th will be given a dividend of $0.335 per share on Monday, April 2nd. This represents a $1.34 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Wednesday, March 14th. This is a positive change from Albemarle's previous quarterly dividend of $0.32. View Albemarle's Dividend History.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) announced its quarterly earnings results on Tuesday, February, 27th. The specialty chemicals company reported $1.34 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.21 by $0.13. The specialty chemicals company had revenue of $857.79 million for the quarter, compared to analysts' expectations of $791.46 million. Albemarle had a net margin of 1.79% and a return on equity of 13.27%. View Albemarle's Earnings History.

When is Albemarle's next earnings date?

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, May, 9th 2018. View Earnings Estimates for Albemarle.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle issued an update on its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of $5.00-5.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.14. The company issued revenue guidance of $3.2-3.4 billion, compared to the consensus revenue estimate of $3.23 billion.

What price target have analysts set for ALB?

23 analysts have issued 12 month price objectives for Albemarle's stock. Their forecasts range from $36.00 to $157.00. On average, they expect Albemarle's share price to reach $125.5481 in the next year. View Analyst Ratings for Albemarle.

What are Wall Street analysts saying about Albemarle stock?

Here are some recent quotes from research analysts about Albemarle stock:

1. KeyCorp analysts commented, "ITRI beat 4Q17 consensus on top/bottom line while guiding FY18 adj. EPS midpoint 2% below Street. Amid moving parts—Silver Spring (now “Networks”) integration, a new restructuring program, and ongoing impacts from 2016 restructuring—we have three primary takeaways. First, we think FY18 guidance embeds healthy organic growth at legacy Itron, supported by 12-month backlog up 22%. Second, we see revenue recog. timing at Networks as a potential dilutive factor in FY18 guidance (on top of Networks’ already higher cost structure) that understates margin expansion at legacy Itron. Third, we believe the restructuring plan is mainly a continuation of existing optimization programs and supports our view of the long-term adj. EBITDA trajectory (which moves slightly lower along with our PT to $77). Maintain Outperform." (3/1/2018)
2. According to Zacks Investment Research, "Albemarle has outperformed the industry it belongs to over a year. Albemarle remains focused on strengthening its lithium business. It is well placed to leverage strong expected growth in the battery-grade lithium market. The company should also gain from the synergies of Rockwood Holdings acquisition. Albemarle is also divesting non-core assets to boost growth opportunities and focus on its key businesses. Moreover, the company remains committed to deliver incremental returns to shareholders. However, Albemarle faces headwinds associated with higher expected operational costs and high tax rate in 2017. Moreover, unfavorable impacts of Hurricane Harvey may continue to affect its results." (12/19/2017)

Who are some of Albemarle's key competitors?

Some companies that are related to Albemarle include Eastman Chemical (EMN), Shanghai Petrochemical (SHI), Mexichem (MXCHY), Hexcel (HXL), PolyOne (POL), Trinseo (TSE), Rogers (ROG), Kraton (KRA), A. Schulman (SHLM) and AdvanSix (ASIX).

Who are Albemarle's key executives?

Albemarle's management team includes the folowing people:

Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 53)
Mr. Scott A. Tozier, Exec. VP & CFO (Age 52)
Mr. Donald J. LaBauve Jr., Chief Accounting Officer, VP & Corp. Controller (Age 51)
Ms. Karen G. Narwold, Chief Admin. Officer, Exec. VP, Gen. Counsel & Corp. Sec. (Age 58)
Mr. Matthew K. Juneau, Exec. VP of Corp. Strategy & Investor Relations (Age 57)

Has Albemarle been receiving favorable news coverage?

Press coverage about ALB stock has trended somewhat positive recently, according to Accern. The research group identifies positive and negative media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Albemarle earned a daily sentiment score of 0.05 on Accern's scale. They also gave news headlines about the specialty chemicals company an impact score of 46.85 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $97.75.

How big of a company is Albemarle?

Albemarle has a market capitalization of $10.81 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

How can I contact Albemarle?

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.

MarketBeat Community Rating for Albemarle (ALB)

Community Ranking:		2.9 out of 5 ( )
Outperform Votes:		505 (Vote Outperform)
Underperform Votes:		379 (Vote Underperform)
Total Votes:		884

MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.

Albemarle (NYSE:ALB) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

23 Wall Street analysts have issued ratings and price targets for Albemarle in the last 12 months. Their average twelve-month price target is $125.5481, suggesting that the stock has a possible upside of 28.44%. The high price target for ALB is $157.00 and the low price target for ALB is $36.00. There are currently 4 hold ratings and 19 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.83	2.78	2.65	2.63
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 19 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 18 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 7 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 7 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$125.5481	$126.6910	$126.2374	$123.7895
Price Target Upside:	28.44% upside	31.37% upside	7.06% upside	10.76% downside

Albemarle (NYSE:ALB) Consensus Price Target History

Price Target History for Albemarle (NYSE:ALB)

Albemarle (NYSE:ALB) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/17/2018	Royal Bank of Canada	Reiterated Rating	Buy	$113.00	Low
4/13/2018	Citigroup	Upgrade	Neutral -> Buy	$106.00	Low
4/12/2018	KeyCorp	Lower Price Target	Overweight -> Overweight	$148.00 -> $140.00	Low
3/27/2018	Argus	Lower Price Target	Buy	$148.00 -> $125.00	Medium
3/6/2018	Seaport Global Securities	Reiterated Rating	Neutral -> Buy		Medium
3/2/2018	BMO Capital Markets	Reiterated Rating	Outperform -> Outperform	$160.00 -> $130.00	Low
3/2/2018	Loop Capital	Set Price Target	Buy	$130.00	Low
3/1/2018	Nomura	Lower Price Target	Buy -> Buy	$161.00 -> $141.00	High
3/1/2018	SunTrust Banks	Boost Price Target	Hold	$110.00	High
2/27/2018	Morgan Stanley	Initiated Coverage	Buy	$150.00 -> $150.00	High
2/27/2018	Berenberg Bank	Initiated Coverage	Buy -> Buy	$150.00	Low
1/30/2018	UBS	Upgrade	Neutral -> Buy	$113.00 -> $150.00	Low
1/19/2018	Jefferies Group	Lower Price Target	Buy	$150.00	Medium
1/17/2018	Oppenheimer	Reiterated Rating	Buy		Medium
1/8/2018	Robert W. Baird	Upgrade	Neutral -> Outperform	$131.72 -> $133.51	High
11/14/2017	Deutsche Bank	Downgrade	Buy -> Hold		N/A
10/13/2017	Instinet	Reiterated Rating	Buy	$146.00 -> $154.00	N/A
10/6/2017	Goldman Sachs	Downgrade	Buy -> Neutral	$139.66 -> $142.00	N/A
8/17/2017	CIBC	Initiated Coverage	Outperform -> Outperform	$133.00	Low
8/10/2017	Vertical Research	Reiterated Rating	Hold	$108.00 -> $109.00	Low
7/7/2017	Aegis	Reiterated Rating	Buy		Medium
6/29/2017	Piper Jaffray	Reiterated Rating	Overweight	$47.00	Low
6/29/2017	Needham & Company LLC	Reiterated Rating	Buy	$36.00	Low

(Data available from 4/23/2016 forward)

Albemarle (NYSE:ALB) Earnings History and Estimates Chart

Earnings by Quarter for Albemarle (NYSE:ALB)

Albemarle (NYSE:ALB) Earnings Estimates

2018 EPS Consensus Estimate: $5.14
2019 EPS Consensus Estimate: $5.87

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	5	$1.15	$1.23	$1.18
Q2 2018	6	$1.13	$1.26	$1.20
Q3 2018	5	$1.20	$1.28	$1.26
Q4 2018	5	$1.41	$1.64	$1.49
Q1 2019	1	$1.33	$1.33	$1.33
Q2 2019	1	$1.41	$1.41	$1.41
Q3 2019	1	$1.48	$1.48	$1.48
Q4 2019	1	$1.65	$1.65	$1.65

Albemarle (NYSE ALB) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/9/2018		$1.20					N/A
5/1/2018		$1.21					N/A
2/27/2018	Q4 2017	$1.21	$1.34	$791.46 million	$857.79 million	View	Listen
11/8/2017	Q3 2017	$1.07	$1.08	$732.19 million	$755.00 million	View	N/A
8/7/2017	Q2 2017	$1.11	$1.13	$735.50 million	$737.25 million	View	Listen
5/3/2017	Q1 2017	$0.95	$1.05	$678.74 million	$722.06 million	View	Listen
2/27/2017	Q416	$0.73	$0.78	$642.68 million	$696.70 million	View	Listen
11/7/2016	Q316	$0.81	$0.91	$645.81 million	$654.00 million	View	Listen
8/3/2016	Q216	$1.00	$1.09	$860.40 million	$669.30 million	View	Listen
5/10/2016	Q116	$0.86	$1.12	$821.64 million	$865.40 million	View	Listen
2/17/2016	Q415	$0.83	$1.03	$891.88 million	$930.40 million	View	Listen
11/4/2015	Q315	$0.89	$0.90	$950.25 million	$905.10 million	View	Listen
8/5/2015	Q215	$0.82	$0.84	$940.65 million	$931.50 million	View	Listen
5/6/2015	Q115	$0.71	$1.17	$913.20 million	$884.40 million	View	Listen
1/28/2015	Q414	$1.01	$0.99	$638.76 million	$598.00 million	View	Listen
10/22/2014	Q314	$1.02	$1.14	$617.70 million	$642.40 million	View	Listen
7/30/2014	Q214	$1.09	$1.10	$646.75 million	$604.70 million	View	Listen
4/16/2014	Q114	$0.95	$0.96	$655.87 million	$656.70 million	View	Listen
1/29/2014	Q413	$1.21	$1.08	$688.58 million	$692.00 million	View	Listen
10/17/2013	Q313	$1.08	$1.09	$655.97 million	$648.80 million	View	Listen
7/17/2013	Q2 2013	$0.98	$0.97	$654.31 million	$634.20 million	View	Listen
4/17/2013	Q1 2013	$1.02	$0.93	$681.09 million	$641.60 million	View	Listen
1/22/2013	Q4 2012	$0.98	$1.17	$646.83 million	$687.60 million	View	Listen
10/17/2012		$1.11	$1.10			View	N/A
7/17/2012		$1.22	$1.24			View	N/A
4/18/2012		$1.16	$1.20			View	N/A
1/23/2012		$1.09	$1.11			View	N/A
10/24/2011		$1.18	$1.28			View	N/A
7/21/2011		$1.12	$1.23			View	N/A
4/19/2011		$0.96	$1.15			View	N/A
1/24/2011		$0.88	$0.92			View	N/A
10/21/2010	Q3 2010	$0.84	$1.02			View	N/A
7/26/2010	Q2 2010	$0.76	$0.89			View	N/A
4/26/2010	Q1 2010	$0.63	$0.74			View	N/A
1/25/2010	Q4 2009	$0.57	$0.64			View	N/A
10/26/2009	Q3 2009	$0.55	$0.57			View	N/A
7/22/2009	Q2 2009	$0.33	$0.41			View	N/A
4/27/2009	Q1 2009	$0.28	$0.28			View	N/A
1/26/2009	Q4 2008	$0.48	$0.42			View	N/A
10/27/2008	Q3 2008	$0.65	$0.61			View	N/A
7/21/2008	Q2 2008	$0.66	$0.67			View	N/A
4/21/2008	Q1 2008	$0.66	$0.70			View	N/A
1/28/2008	Q4 2007	$0.59	$0.60			View	N/A

(Earnings results data provided by Zacks Investment Research)

Albemarle (NYSE:ALB) Dividend Information

Albemarle pays an annual dividend of $1.34 per share, with a dividend yield of 1.37%. ALB's most recent quarterly dividend payment was Monday, April 2. The company has grown its dividend for the last 14 consecutive years and is increasing its dividend by an average of 5.90% each year. Albemarle pays out 29.19% of its earnings out as a dividend.

Most Recent Dividend:	4/2/2018
Annual Dividend:	$1.34
Dividend Yield:	1.37%
Dividend Growth:	5.90% (3 Year Average)
Payout Ratio:	29.19% (Trailing 12 Months of Earnings) 26.02% (Based on This Year's Estimates) 23.02% (Based on Next Year's Estimates)
Track Record:	14 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Albemarle (NYSE:ALB)

Albemarle (NYSE:ALB) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/23/2018	quarterly	$0.3350	1.17874736101337%	3/14/2018	3/15/2018	4/2/2018
11/6/2017	quarterly	$0.32		12/14/2017	12/15/2017	1/2/2018
7/10/2017	quarterly	$0.32	1.14%	9/14/2017	9/15/2017	10/2/2017
5/11/2017	quarterly	$0.32	1.16%	6/13/2017	6/15/2017	7/3/2017
2/23/2017	quarterly	$0.32	1.38%	3/13/2017	3/15/2017	4/3/2017
11/3/2016	quarterly	$0.3050	1.46%	12/13/2016	12/15/2016	1/2/2017
7/11/2016	quarterly	$0.3050	1.43%	9/13/2016	9/15/2016	10/3/2016
5/10/2016	quarterly	$0.3050	1.63%	6/13/2016	6/15/2016	7/1/2016
2/26/2016	quarterly	$0.3050	2.17%	3/14/2016	3/16/2016	4/1/2016
10/5/2015	quarterly	$0.29	2.44%	12/11/2015	12/15/2015	1/4/2016
7/9/2015	quarterly	$0.29	2.15%	9/14/2015	9/16/2015	10/1/2015
5/6/2015	quarterly	$0.29	1.93%	6/12/2015	6/16/2015	7/1/2015
5/5/2015	quarterly	$0.29			6/16/2015	6/1/2015
2/24/2015	quarterly	$0.29	2.06%	3/12/2015	3/16/2015	4/1/2015
10/14/2014	quarterly	$0.2750	2.04%	12/11/2014	12/15/2014	1/2/2015
7/14/2014	quarterly	$0.2750	1.57%	9/11/2014	9/15/2014	10/1/2014
5/13/2014	quarterly	$0.2750	1.59%	6/11/2014	6/13/2014	7/1/2014
2/25/2014	quarterly	$0.2750	1.68%	3/12/2014	3/14/2014	4/1/2014
10/8/2013	quarterly	$0.24	1.52%	12/11/2013	12/13/2013	1/2/2014
7/10/2013	quarterly	$0.24	1.48%	9/11/2013	9/13/2013	10/1/2013
5/7/2013	quarterly	$0.24	1.51%	6/12/2013	6/14/2013	7/1/2013
2/12/2013	quarterly	$0.24	1.45%	3/13/2013	3/15/2013	4/1/2013

(Data available from 1/1/2013 forward)

Albemarle (NYSE ALB) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 86.44%

Insider Trading History for Albemarle (NYSE:ALB)

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Albemarle (NYSE ALB) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/24/2017	Matthew Juneau	EVP	Sell	5,397	$115.77	$624,810.69	360
8/23/2017	Karen G Narwold	EVP	Sell	11,500	$115.95	$1,333,425.00	36,620
7/7/2017	Luther C Iv Kissam	Chairman	Sell	50,000	$110.08	$5,504,000.00	252,917
7/7/2017	Scott Tozier	CFO	Sell	25,000	$110.13	$2,753,250.00	57,506
6/19/2017	Douglas L Maine	Director	Sell	10,000	$107.94	$1,079,400.00	24,150
6/19/2017	Karen G Narwold	EVP	Sell	20,000	$108.16	$2,163,200.00	45,120
1/6/2017	Karen G Narwold	EVP	Sell	392	$90.59	$35,511.28	22,284
1/6/2017	Luther C Iv Kissam	Chairman	Sell	2,542	$90.46	$229,949.32	190,628
1/6/2017	Scott Tozier	CFO	Sell	1,057	$90.62	$95,785.34	29,722
12/6/2016	Karen G Narwold	EVP	Sell	10,000	$86.11	$861,100.00	31,108
8/24/2016	Luther C Iv Kissam	CEO	Sell	50,000	$83.19	$4,159,500.00	233,000
8/5/2016	John Sherman Jr	Director	Sell	4,300	$82.09	$352,987.00	1,500
5/12/2016	Donald J Jr. Labauve	CAO	Sell	3,564	$75.34	$268,511.76	3,464
5/12/2016	John Sherman Jr	Director	Sell	2,025	$75.73	$153,353.25	1,850
5/12/2016	Matthew Juneau	SVP	Sell	13,174	$75.34	$992,529.16	360
3/14/2016	Karen G Narwold	SVP	Sell	405	$60.38	$24,453.90	21,108
3/8/2016	Scott Tozier	CFO	Sell	556	$58.89	$32,742.84	28,665
3/1/2016	Luther C Iv Kissam	CEO	Sell	1,048	$57.98	$60,763.04	191,103
1/6/2016	Karen G Narwold	SVP	Sell	138	$52.57	$7,254.66	19,893
1/6/2016	Scott Tozier	CFO	Sell	190	$52.55	$9,984.50	26,998
9/1/2015	Luther C. Iv Kissam	CEO	Buy	4,533	$44.01	$199,497.33	170,777
3/2/2015	Luther C Iv Kissam	CEO	Sell	1,075	$56.36	$60,587.00
2/11/2015	James J /Ky Obrien	Director	Buy	1,000	$52.68	$52,680.00
2/3/2015	John Sherman Jr	Director	Buy	2,500	$48.49	$121,225.00
2/2/2015	Jim W Nokes	Director	Buy	3,000	$47.47	$142,410.00
1/30/2015	Douglas L Maine	Director	Buy	7,847	$48.48	$380,422.56
9/12/2014	Gerald A Steiner	Director	Buy	1,000	$64.21	$64,210.00
8/1/2014	D Michael Wilson	SVP	Buy	5,000	$61.29	$306,450.00
2/25/2014	Karen Narwold	VP	Sell	2,200	$64.41	$141,702.00	15,388
2/25/2014	Scott Tozier	CFO	Sell	3,509	$64.44	$226,119.96	28,473
1/30/2014	John Sherman, Jr.	Director	Sell	1,000	$65.27	$65,270.00	1,600
1/30/2014	Matthew Juneau	SVP	Sell	5,000	$64.84	$324,200.00	6,519
1/8/2014	Luther Iv Kissam	CEO	Sell	3,180	$64.41	$204,823.80	160,779
1/8/2014	Scott Tozier	CFO	Sell	1,339	$64.35	$86,164.65	31,403

(Data available from 1/1/2013 forward)

Albemarle (NYSE ALB) News Headlines

Source:

Date	Headline
	Global Bromine Business 2018: Leading Players are Albemarle, Israel Chemicals Ltd, Jordan Bromine, LANXESS ... www.prnewswire.com - April 20 at 5:28 PM
	BRIEF-Albemarle Declares Force Majeure On Shortage Of Key Raw Materials In Urethane Supply Chain www.reuters.com - April 19 at 5:47 PM
	Why Albemarle Corporation's Outlook Is Still Strong Despite Recent Slump seekingalpha.com - April 19 at 5:47 PM
	Albemarle Declares Force Majeure Due to Shortage of Key Raw Materials in Urethane Supply Chain finance.yahoo.com - April 19 at 5:47 PM
	Albemarle Corporation to present at Barclays Electronic Chemicals Conference finance.yahoo.com - April 18 at 5:50 PM
	Reviewing AdvanSix (ASIX) & Albemarle (ALB) www.americanbankingnews.com - April 18 at 11:18 AM
	Albemarle (ALB) Stock Rating Reaffirmed by Robert W. Baird www.americanbankingnews.com - April 17 at 6:29 PM
	Royal Bank of Canada Reaffirms Buy Rating for Albemarle (ALB) www.americanbankingnews.com - April 17 at 8:17 AM
	Brokerages Expect Albemarle Co. (ALB) Will Announce Quarterly Sales of $806.51 Million www.americanbankingnews.com - April 17 at 2:38 AM
	BRIEF-Albemarle Corp Announces Appointment Of Glen Merfeld As Chief Technology Officer For Lithium Business www.reuters.com - April 16 at 5:31 PM
	Albemarle Corporation Announces Appointment of Dr. Glen Merfeld, Chief Technology Officer for Lithium Business finance.yahoo.com - April 16 at 5:31 PM
	3 Stocks to Buy on Weakness Now investorplace.com - April 16 at 2:57 PM
	Albemarle (ALB) Rating Lowered to Buy at BidaskClub www.americanbankingnews.com - April 16 at 12:02 PM
	Should You Be Tempted To Sell Allgäuer Brauhaus AG (MUN:ALB) Because Of Its PE Ratio? finance.yahoo.com - April 16 at 8:10 AM
	Analysts Anticipate Albemarle Co. (ALB) to Announce $1.20 EPS www.americanbankingnews.com - April 15 at 7:17 PM
	Albemarle (ALB) Lowered to "Hold" at BidaskClub www.americanbankingnews.com - April 14 at 8:31 AM
	Albemarle (ALB) Rating Increased to Buy at Citigroup www.americanbankingnews.com - April 13 at 10:37 AM
	Citi Upgrades Albemarle (ALB) to Buy www.streetinsider.com - April 13 at 8:13 AM
	Albemarle (ALB) Rating Reiterated by KeyCorp www.americanbankingnews.com - April 12 at 9:47 AM
	Albemarle (ALB) Stock Rating Lowered by SunTrust Banks www.americanbankingnews.com - April 12 at 12:29 AM
	Albemarle Co. (ALB) Receives Consensus Rating of "Buy" from Brokerages www.americanbankingnews.com - April 11 at 11:37 AM
	Citigroup Trims Albemarle (ALB) Target Price to $95.00 www.americanbankingnews.com - April 10 at 11:29 AM
	Free Research Report as Albemarle’s Quarterly Sales Jumped 23.1%; Adjusted EPS Surged 72% finance.yahoo.com - April 10 at 8:16 AM
	Albemarle (ALB) Given a $144.00 Price Target by Jefferies Group Analysts www.americanbankingnews.com - April 9 at 11:27 PM
	Albemarle Corporation to release first quarter 2018 earnings results on May 9, 2018 finance.yahoo.com - April 9 at 5:28 PM
	Albemarle (ALB) Price Target Increased to $154.00 by Analysts at Nomura www.americanbankingnews.com - April 7 at 4:29 PM
	Albemarle (ALB) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - April 6 at 9:16 PM
	Albemarle (ALB) Earns "Buy" Rating from Jefferies Group www.americanbankingnews.com - April 6 at 12:28 AM
	Should Value Investors Pick Albemarle (ALB) Stock Now? www.nasdaq.com - April 3 at 5:41 PM
	Albemarle completes sale of portion of Performance Catalysts Solutions to WR Grace & Co. www.prnewswire.com - April 3 at 5:41 PM
	BRIEF-Albemarle Completes Sale Of Portion Of Performance Catalysts Solutions To WR Grace & Co. www.reuters.com - April 3 at 5:41 PM
	Robert W. Baird Reaffirms "Hold" Rating for Albemarle (ALB) www.americanbankingnews.com - April 2 at 12:23 PM
	Albemarle (ALB) Price Target Increased to $150.00 by Analysts at UBS www.americanbankingnews.com - March 31 at 6:34 PM
	Albemarle Co. (ALB) Expected to Post Quarterly Sales of $806.51 Million www.americanbankingnews.com - March 31 at 2:10 AM
	Zacks: Brokerages Anticipate Albemarle Co. (ALB) to Post $1.20 Earnings Per Share www.americanbankingnews.com - March 29 at 9:14 PM
	Albemarle (ALB) Down 16.3% Since Earnings Report: Can It Rebound? finance.yahoo.com - March 29 at 5:35 PM
	Argus Trims Albemarle (ALB) Target Price to $125.00 www.americanbankingnews.com - March 27 at 9:31 AM
	Albemarle (ALB) Lifted to "Buy" at UBS www.americanbankingnews.com - March 26 at 3:42 PM
	Reviewing Albemarle (ALB) & Mitsubishi Chemical (MTLHY) www.americanbankingnews.com - March 26 at 3:05 AM
	Albemarle (ALB) Coverage Initiated at Berenberg Bank www.americanbankingnews.com - March 24 at 9:29 PM
	Bought Albemarle In 2 Stages, Looking At Adding More As Lithium Negativity Continues seekingalpha.com - March 24 at 5:21 PM
	TheStreet Downgrades Albemarle (ALB) to C+ www.americanbankingnews.com - March 24 at 2:13 PM
	Allgäuer Brauhaus AG (MUN:ALB): Should The Recent Earnings Drop Worry You? finance.yahoo.com - March 23 at 8:13 AM
	Are Chemical & Mining Co. Of Chile, FMC Corp., And Albemarle Buys Right Now? seekingalpha.com - March 21 at 5:44 PM
	6 Key Things About Albemarle's Lithium Business and Outlook That Investors Should Know finance.yahoo.com - March 17 at 6:13 PM
	Albemarle Co. (ALB) Receives Average Rating of "Buy" from Analysts www.americanbankingnews.com - March 17 at 11:39 AM
	North Carolina county will arm volunteers to protect its schools www.foxnews.com - March 15 at 6:20 PM
	Analysts Anticipate Albemarle Co. (ALB) Will Post Earnings of $1.19 Per Share www.americanbankingnews.com - March 12 at 7:24 PM
	U.S. Lithium Mining Could Get a Boost From President Trump's Executive Order finance.yahoo.com - March 10 at 8:14 AM
	BRIEF-Albemarle Receives Increase In Lithium Quota For Chile Operations www.reuters.com - March 9 at 6:59 PM

Albemarle (NYSE:ALB) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Albemarle (NYSE:ALB) Income Statement, Balance Sheet and Cash Flow Statement

Albemarle (NYSE ALB) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff